Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Jun 2026 for Orchestra BioMed Holdings, Inc..
Filing timeline
BuySalePamela Ann Connealy
Insider track record
Disclosed buys
6
Disclosed sells
0
Signal history
Closed purchases
Market purchases
5
Positive at T+90
0%
Median T+90
-10.1%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +158.2%Entry US$2.01 · Close at T+365 US$5.19
- +84.4%Entry US$1.99 · Close at T+365 US$3.67
- +77.5%Entry US$2.04 · Close at T+365 US$3.62
- +88.7%Entry US$1.86 · Close at T+365 US$3.51
- +102.2%Entry US$1.78 · Close at T+365 US$3.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Pamela Ann Connealy: trading record in brief
This profile gathers the share dealings of Pamela Ann Connealy across 2 companies, led by Pyxis Oncology, Inc. and Orchestra BioMed Holdings, Inc. Between 20 July 2023 and 23 June 2026, the trades on record add up to 14 filings.
Purchases make up the whole of the open-market record (6 purchases, €219k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 8 share grants.
The median purchase comes to €13k. Clusters matter here: 4 out of 6 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -10.1%. These figures describe past trades and do not predict future prices.
The newest entry dates from 25 June 2026: a share grant, in Orchestra BioMed Holdings, Inc. The latest purchase dates back some time: it was published 695 days ago, on 27 November 2024. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Pamela Ann Connealy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
17,327 sharesCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-077775:0
15,000 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-075786:0
12,422 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-063095:0
5,450 shares@ US$2.009.5% of flowCommon StockSEC:0000950170-24-131606:0
Canonical exit: 24 Feb 2025 (T+90)
5,376 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-24-074013:0
328,710 shares0Common StockSEC:0000950170-24-038108:0
36,949 shares@ US$1.4042.7% of flowCommon StockSEC:0001209191-23-056969:0
8,000 shares@ US$1.8712.9% of flowCommon StockSEC:0001209191-23-050734:0
Canonical exit: 27 Dec 2023 (T+90)
6,426 shares@ US$1.846810.3% of flowCommon StockSEC:0001209191-23-050685:0
Canonical exit: 26 Dec 2023 (T+90)
12,000 shares@ US$1.670317.2% of flowCommon StockSEC:0001209191-23-050492:0
Canonical exit: 24 Dec 2023 (T+90)
5,000 shares@ US$1.7397.4% of flowCommon StockSEC:0001209191-23-050432:0
Canonical exit: 21 Dec 2023 (T+90)
187,793 shares0Common StockSEC:0001209191-23-048819:0
11,667 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-23-083499:0
13 of 13 declarations
